SYNTAGMA CAPITAL enters into exclusive negotiations to acquire Nexans’ LAN/data center (“LAN/DC”) and Telecom /Fibre (“FTTx”) division.
Syntagma Capital today announces that it has entered into exclusive negotiations with Nexans SA to acquire its LAN/data center (“LAN/DC”) and Telecom /Fibre (“FTTx”) division. The business designs, manufactures, and distributes smart connectivity solutions based on optical fibre and copper technologies to data centers, smart buildings, and telecom operators. The business is headquartered in Paris, France and employs ca. 680 people across its 8 sites located in France, Belgium, Germany, Greece, Morocco and China, and it generated ca. €200m in revenues across 100+ countries.
The proposed transaction, which is subject to the fulfillment of customary closing conditions, including the information and consultation of works councils and other regulatory approvals, is expected to be completed by the end of the first half of 2023.
“We are pleased to partner with management to continue to grow the business. Providing the backbone for data management is an exciting prospect. Despite a challenging M&A market, we are continuing to find attractive opportunities to invest our capital while providing sellers with divestiture solutions for complex carve outs where speed and certainty are of the essence. This transaction represents our most recent carve out and reflects Syntagma’s strategy to acquire businesses that will benefit from a new owner to drive the next area of growth” said Syntagma Managing Partner Sebastien Kiekert Le Moult.
Christopher Guérin, Chief Executive Officer of Nexans declared: “We are pleased that our Telecom Systems colleagues will join a strategic new home with Syntagma Capital to further invest and grow the business. This powerful combination will deliver meaningful opportunities to employees and customers. I would like to thank the teams for the excellent work they have done in the past, and I am confident in their future development.”
“Syntagma’s ability to manage complex carve out was critical in differentiating us. The business provides significant opportunities to grow in the coming years” said Syntagma Partner Frank Coenen. “We expect to leverage the company’s extensive technical know-how, global presence and strong customer relationships, to accelerate its growth, both organically and through targeted M&A investments in key product areas and geographies.”
Syntagma’s team involved in the transaction included Sebastien Kiekert Le Moult (Managing Partner), Frank Coenen (Partner), Benjamin Dahan (Partner), João Pilecco (Senior Vice President), and Ludovic Ruffenach (Senior Associate).
Willkie Farr & Gallagher provided legal counsel to Syntagma, PwC provided financial, legal, tax, and social advice, Roland Berger provided commercial and strategy support, and ERM advised on ESG and EHS matters.
About Syntagma Capital
Syntagma invests in companies that can benefit from hands-on operational expertise to accelerate growth and improve performance for all stakeholders. We are true operators with experience working in and managing companies on a global scale, leveraging our in-house resources to develop successful strategies, execute them to realize their full potential and create sustainable long-term value. Syntagma invests and operates companies in a broad range of industries with a specific focus on the material, chemical, industrial and business services markets and including manufacturing, distribution, transportation and logistics, equipment rental, metals services and other industries. Syntagma, as signatory of the UN PRI, is committed to high ESG standards across all its investments and is based in Brussels, Belgium. For more information, please visit: https://syntagmacapital.com
About Nexans
For more than a century, Nexans has played a crucial role in electrifying the planet and is committed to electrifying the future. With almost 25,000 staff in 42 countries, the Group is driving the change towards the new world of electrification: a safer, more sustainable, renewable, carbon-free world, accessible to all. In 2021, Nexans generated €6.1 billion in standard sales. The Group is a leader in the design and manufacture of cable systems and services in five main areas of activity: Energy Production & Transmission, Distribution, Uses, Industry & Solutions and Telecom & Data. Nexans was the first player in its industry to create a Corporate Foundation to support actions that promote access to energy for disadvantaged populations worldwide. The Group is committed to helping achieve carbon neutrality by 2030.
Nexans. Electrify the future.
Nexans is listed on the Euronext Paris stock market, compartment A.
For more information, please visit www.nexans.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230205005028/en/
Contact information
Marie Ciparisse
Phone: +32 (0)2 315 70 12
Email mciparisse@syntagmacapital.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Study Suggests Critical Link Between Residual FLT3 -ITD Mutations in Remission and Post-Transplant Outcomes in AML8.5.2024 16:00:00 CEST | Press release
A groundbreaking research study,1 sequencing DNA samples from the Pre-MEASURE study2 strongly indicates that the detection of residual FLT3 internal tandem duplication (ITD) mutations in the blood of adult subjects with acute myeloid leukemia (AML) in first complete remission (CR) is associated with worse outcomes after post allogeneic hematopoietic cell transplant (HCT). This follow-up study performed measurable residual disease (MRD) testing on DNA of 537 subjects with FLT3-ITD AML from the Pre-MEASURE study using Invivoscribe’s RUO FLT3 ITD MRD Assay kit and bioinformatics software. Its findings underscore the likely significance of residual FLT3-ITD in first CR in predicting relapse and mortality post-transplant. A key finding from this research study was that AML subjects with residual FLT3-ITD detected prior to allogeneic HCT trended towards elevated risk of relapse and mortality post-transplant, with a dose-dependent correlation within this study population. Dr. Hourigan, Direct
RunPod Raises $20M in Seed Funding Co-led by Intel Capital and Dell Technologies Capital8.5.2024 15:07:00 CEST | Press release
RunPod, the launchpad that empowers developers to deploy custom full-stack AI applications, today announced it raised $20M in Seed funding, co-led by Intel Capital and Dell Technologies Capital with participation from Julien Chaummond, Nat Friedman, and Adam Lewis. In conjunction with the financing, Mark Rostick, Vice President and Senior Managing Director at Intel Capital, will join RunPod’s board of directors. RunPod is a globally distributed GPU cloud computing service for training, deploying, and scaling AI models. Using RunPod’s two core products, GPU Cloud and Serverless, developers can spin up an on-demand GPU instance in a few clicks and create autoscaling API endpoints for scaling inference on AI models in production. “The ability to create and deploy AI applications at scale will be paramount to their adoption and utilization,” said Amjad Masad, RunPod investor. “The RunPod team has clearly prioritized the developer experience to create an elegant solution that enables indivi
Tigo Energy Delivers Most Powerful Solar MLPE for High-Wattage and Bifacial Modules8.5.2024 15:00:00 CEST | Press release
Tigo Energy, Inc. (NASDAQ: TYGO), a leading provider of intelligent solar and energy software solutions, today announced the newest additions to the Tigo Flex MLPE product family, the Tigo TS4-X line. Designed to serve the commercial and industrial (C&I) as well as utility solar markets, Tigo TS4-X products support the latest high-power solar modules, up to 800W. Members of the TS4-X product family feature compatibility with Pure Signal™ technology in Tigo RSS Transmitters and offer a Multi-Factor Rapid Shutdown (MFRS) option with redundant safety signaling for solar systems serving the food and pharmaceutical cold-chain sectors, or other energy-critical applications. The new devices pair with an industry-leading list of third-party solar inverters to deliver design and installation flexibility for solar installers and engineering, procurement, and construction specialists (EPCs). As Levelized Cost Of Energy (LCOE) continues to drive the large-scale solar sectors, the TS4-X product lin
Cyolo Partners with Dragos to Unveil Holistic Secure Remote Access Solution for Critical Infrastructure8.5.2024 14:30:00 CEST | Press release
Cyolo, the secure remote access company for operational technology (OT) and industrial control systems (ICS), today announced a strategic partnership with Dragos, a global leader in cybersecurity for ICS/OT. Under the umbrella of Cyolo’s CyoloVerse partner program, Cyolo's PRO Secure Remote Access Platform will work with Dragos’s industry-leading OT cybersecurity platform. This collaboration will provide organizations with a robust and interoperable solution to protect their critical infrastructure against cyber threats. New technology implementations in ICS/OT environments pose unique risks for critical infrastructure. Today’s risks include lack of support for modern authentication or connectivity methods in traditional environments, connecting existing infrastructure with highly vulnerable end-of-life operating systems, or risk of breaches from third-party remote access. This interoperability is designed to provide OT customers visibility and management of their asset inventory and e
John Patton, Head of Kindeva Drug Delivery’s Scientific Advisory Board, Named Winner of RDD Conference’s Charles G. Thiel Award8.5.2024 14:00:00 CEST | Press release
At the recent Respiratory Drug Delivery (RDD) Conference, John Patton, Ph.D., biotechnology scientist and entrepreneur and Head of the Scientific Advisory Board (SAB) for Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, was announced as the winner of the Charles G. Thiel Award. This prestigious award is given once every two years at RDD Conferences to one scientist who has been voted by his or her peers to have pioneered significant developments in one or more aspects of the science and technology surrounding respiratory drug delivery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240508931671/en/ Biotechnology scientist and entrepreneur and Kindeva Drug Delivery’s Head of the Scientific Advisory Board, John Patton (second from the left), was named the winner of the Charles G. Thiel Award for outstanding research and discovery in respiratory drug delivery at this year’s Respiratory Drug